Shaanxi University of Science and Technology

Shaanxi Panlong Pharmaceutical Co., Ltd.

Xi'an Taikomed Pharmaceutical Technology Co., Ltd.

Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd.

Juan Xia

Chengyuan Liang

Han Li

Lei Tian

Nan Qin

Jingyi Li

Liang Xin

Yuzhi Liu

Xiaolin Xie

Dezhu Zhang

Xuechuan Wang

Kangxiong Wu

Shaojun Zhang

Zhenfeng Shi

Xingke Ju

Qianqian Zhao

Taotao Qiang

Xuhua Zhou

Zhao Ma

Qingbo Zhao

Min Li

Catherine J Lee

Maggie Lewis

Shaomeng Pei

Bin Tian

Yu Wang

Juan Li

Gennian Mao

Nan Hui

Yonghong Tang

Jie Zhang

Danni Tian

Minghui Chang

Shunjun Ding

Xiuding Yang

Yuqing Zhao

Jianguo Meng

Zhong Meng

Kaiqi Shi

Mi Wu

Jiayun Zhang

A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I) R, R, R, Rand Rare independently hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl or dimethylamino.

Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections

A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. The Linker is or and n is 1-6.

Protacs targeting coronavirus 3CL protease and preparation method and application thereof

A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. In formula I and II, n is 1-6.

Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereof

A compound of Formula I: is disclosed. A method of preparing the compound of Formula I is also disclosed. R is alkyl, haloalkyl, aryl, or substituted aryl. Preferably, R is &#x2014;CH, &#x2014;CHCH, &#x2014;CHCHCH, &#x2014;CH(CH), &#x2014;CHCHCHCH, &#x2014;CF, &#x2014;CHF, &#x2014;CHCF, 

Gossypol isocyanate ester compounds with antileukemic activities and a method of preparing the same

A compound of chemical formula I: or chemical formula II: or a pharmaceutical acceptable salt thereof is disclosed. R, R, R, and Rare independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C-Cstraight or branched alkyl, C1-C8 straight or branched haloalkyl, C-Cstraight or branched alkoxy.

Alantolactone/isoalantolactone spiro aryl isoxazoline compounds

A compound of chemical formula I: or formula II: or a pharmaceutical acceptable salt thereof is disclosed. Ris OH or OAc; X is C or N; and Ris H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO, or halogen, provided that when X is N, Ris nil.

1-O-acetylbritannilatone spiro aryl isoxazoline compounds

A compound having the following formula I: is disclosed. A method of preparing the compound of formula I is also disclosed.

Hydroxytyrosol shikimic acid ester for treating cardiovascular deceases and a method of preparing the same

A method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine includes: reacting guanidine hydrochloride with ethyl carbamoylacetate and sodium hypochlorite in the presence of a metal nitrate salt and acetate anhydride in an organic solvent. 

Method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine and its application thereof

Growing community of inventors

Xi'an, China

Juan Xia